Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases
- PMID: 1549056
Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases
Abstract
We evaluated the prognosis of acute porphyria among 206 adult Finnish patients with acute intermittent porphyria (AIP) or variegate porphyria (VP). The series represents all known patients with these porphyrias in Finland. Of the 47 patients who had a total of 117 acute attacks during the period 1967-1989, 6 died during an attack and 21 attacks were associated with paresis; the frequency of severe attacks was significantly smaller than before 1967 (p = 0.00002). Most pareses and deaths occurred because of a delay in diagnosis and inappropriate treatment of porphyria. For those patients who were symptom-free at the time of diagnosis (1365 follow-up years), the risk of the first subsequent attack was significantly smaller than for those who had had an acute attack before the diagnosis of porphyria (1047 follow-up years, p = 0.005). In addition, milder symptoms of porphyria were more common among those who had had previous attacks than among those who had not (p less than 0.00001). In AIP the risk of attacks correlated with the excretion of porphobilinogen in the urine during remission among adults (p = 0.03); a low rate of excretion predicted freedom from acute attacks. A regular use of many precipitating drugs was never associated with symptoms of porphyria. Two percent of the surgical operations and 4% of the pregnancies were associated with acute attacks. Nearly one-third of the women had symptoms of porphyria associated with the menstrual cycle, but these seldom proceeded to an acute attack. Forty-six percent of the women had used sex-hormone preparations regularly; 2 of them (4.5%) experienced associated acute attacks. Patients with AIP or VP showed increased incidences of hepatocellular carcinoma, and probably also chronic renal failure and hypertension.
Similar articles
-
Variegate porphyria. Twelve years' experience in Finland.Q J Med. 1980 Spring;49(194):191-203. Q J Med. 1980. PMID: 7433635
-
Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients.Eur J Hum Genet. 2002 Oct;10(10):649-57. doi: 10.1038/sj.ejhg.5200860. Eur J Hum Genet. 2002. PMID: 12357337
-
[Treatment of acute porphyrias. The importance of follow-up of patients and carriers].Orv Hetil. 2003 May 11;144(19):933-8. Orv Hetil. 2003. PMID: 12809070 Review. Hungarian.
-
Penetrance and predictive value of genetic screening in acute porphyria.Mol Genet Metab. 2020 May;130(1):87-99. doi: 10.1016/j.ymgme.2020.02.003. Epub 2020 Feb 10. Mol Genet Metab. 2020. PMID: 32067921
-
[Acute hepatic porphyria and its neurological syndrome].Schweiz Med Wochenschr. 1996 Jan 9;126(1-2):6-14. Schweiz Med Wochenschr. 1996. PMID: 8571113 Review. German.
Cited by
-
Psychiatric Manifestations in three cases of Acute Intermittent Porphyria.Med J Armed Forces India. 2003 Apr;59(2):171-3. doi: 10.1016/S0377-1237(03)80075-8. Epub 2011 Jul 21. Med J Armed Forces India. 2003. PMID: 27407502 Free PMC article. No abstract available.
-
Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias.Br J Clin Pharmacol. 2007 Nov;64(5):668-79. doi: 10.1111/j.0306-5251.2007.02955.x. Epub 2007 Jun 19. Br J Clin Pharmacol. 2007. PMID: 17578481 Free PMC article. Review.
-
Kidney disease in acute intermittent porphyria: histological features and therapeutic perspectives.J Nephrol. 2024 May;37(4):1165-1169. doi: 10.1007/s40620-023-01828-0. Epub 2024 Apr 20. J Nephrol. 2024. PMID: 38642240 No abstract available.
-
The incidence of inherited porphyrias in Europe.J Inherit Metab Dis. 2013 Sep;36(5):849-57. doi: 10.1007/s10545-012-9544-4. Epub 2012 Nov 1. J Inherit Metab Dis. 2013. PMID: 23114748
-
Porphyrias at a glance: diagnosis and treatment.Intern Emerg Med. 2010 Oct;5 Suppl 1:S73-80. doi: 10.1007/s11739-010-0449-7. Intern Emerg Med. 2010. PMID: 20865478 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous